Getein at India Health 2026 - Innovative Diagnostics for a Brilliant Future Stand Stories: First-Day Buzz 〈New Delhi, August 21 2026〉— India Health 2026 is now underway at Bharat Mandapam, bringing together healthcare professionals, distributors, and industry partners from across India and surrounding markets. Since opening, Getein’s showcase at Hall 6, Booth C12 has drawn a steady stream of visitors eager to explore practical solutions for evolving diagnostic needs.     Presented by the organizers of WHX Dubai, formerly Arab Health, the three-day event serves as an important platform for healthcare innovation and regional collaboration. Through conversations on laboratory efficiency, decentralized testing, and market-specific applications, the Getein team is gaining valuable insights while building stronger connections with partners across the region. Spotlight on Solutions The products featured by Getein at this year's exhibition span chemiluminescence, point-of-care testing, and veterinary biochemistry. MAGICL 6000i streamlines laboratory workflows with a fully automated testing system and intelligent consumables and reagent management modules; the handheld Getein 1150 supports up to eight hours of battery-powered operation for mobile testing; the compact Getein 1100 delivers high-precision testing with both in-device and external testing modes for flexible deployment; and CM-50 Vet combines a disc-shaped reagent cartridge with dry chemistry technology to enable convenient multi-analyte testing in veterinary setting. These featured instruments represent part of Getein's broader portfolio of diagnostic platforms and solutions developed for diverse testing needs.     Still On - Don't Miss Out India Health 2026 continues through August 23. Visit Getein at Hall 6, Booth C12 to discover our latest diagnostic solutions and discuss new opportunities for collaboration.    

Connecting Partners, Empowering Growth | Getein Hosts India Distributor Meeting Strengthening Partnerships in India     Getein Biotech, together with its local partner Ares Labs, hosted the 2026 India Distributor Meeting on August 20 2026, at SK Premium Park in New Delhi. Held under the theme "Grow Together, Win the Future," the meeting brought together representatives from leading diagnostic companies across India. Partners and industry professionals exchanged insights, explored opportunities for collaboration, and discussed the future of India's diagnostics market. The event provided an open platform for closer cooperation. It also highlighted Getein's commitment to bringing reliable, high-performance in vitro diagnostic (IVD) solutions to Indian healthcare institutions while supporting the development of local laboratory capabilities. Guests arrived in the afternoon and took part in informal conversations before the meeting began. The event officially opened at 5:00 p.m. with remarks from Getein's overseas sales team, who thanked all partners for their continued trust and support.     Technology Showcase     During the main session, the Getein team introduced the company's expertise and latest developments across three product lines: chemiluminescence, point-of-care testing (POCT), and hematology.     The fully automated MAGICL 6000 and MAGICL 6000i chemiluminescence immunoassay analyzers are designed to meet laboratories' different throughput requirements, offering a balance of efficiency, accuracy, and reliability. Getein's POCT portfolio ranges from portable semi-automated devices to fully automated, high-throughput systems. These solutions support a variety of settings, including emergency care, decentralized testing, and central laboratories. The BHA series of hematology analyzers includes both 3-part and 5-part differential models, providing complete blood count solutions for a broad range of clinical applications.The BHA series of hematology analyzers includes both 3-part and 5-part differential models, providing complete blood count solutions for a broad range of clinical applications. Participants showed strong interest in the products' technical performance and clinical value. Discussions covered reagent stability, assay menus, equipment capabilities, and laboratory implementation, creating an engaging and productive atmosphere. Clinical Insights The open discussion session focused on practical needs in the Indian market. Participants shared their experience with hospital laboratories and clinical workflows and raised questions about equipment maintenance, testing efficiency, and local service support. These exchanges offered valuable insights into local operating conditions and provided a basis for further cooperation between Getein and its Indian partners.     Growing Together India is one of the world's most dynamic diagnostics markets, with significant potential for continued grow...

Getein Shines at Medical Fair China 2026     On the Show Floor Hall B1, Booth D18 – Multi-scenario diagnostic solutions on display, drawing steady crowds of industry professionals. SUZHOU, August 20, 2026 — The 8th Medical Fair China (MFC 2026) is now underway at the Suzhou International Expo Center. Since the doors opened, Getein Biotech's booth (Hall B1, Booth D18) has been a hub of activity, with a steady stream of visitors making it one of the most frequented destinations on the show floor.     Booth Highlights     The Getein team has been warmly welcoming partners and professionals from across China and overseas markets. From in-depth discussions on precision diagnostic needs to comprehensive solution planning, every conversation has been paving the way for clearer, more collaborative paths forward.     As a premier medical device event bridging China with global markets, this year's MFC (August 20–22) brings together over 350 exhibitors and more than 15,000 experts, scholars, and industry practitioners. Getein's booth, with its comprehensive diagnostic concepts and diverse product portfolio, has drawn considerable attention — and the energy on-site has been nothing short of electric.     Product Highlights     Several of Getein's featured innovations have captured the interest of partners and industry experts alike. The company's comprehensive diagnostic solutions span fluorescent immunoassay (FIA), chemiluminescence, molecular diagnostics, coagulation testing, veterinary diagnostics, as well as clinical biochemistry and hematology analysis — covering everything from emergency and critical care to central laboratory settings, from all-in-one molecular diagnostic to animal health management. Together, they form a robust product matrix tailored to a wide range of clinical scenarios. The standout star of this exhibition — the MAGICL 6000 compact fully automated chemiluminescence analyzer — has been drawing significant crowds. Its small footprint, high throughput, and exceptional precision, combined with effective cross-contamination prevention, make it an ideal fit for both central laboratories and urgent stat testing in outpatient settings.     On the POCT front, the Getein 1160 and Getein 1150 are both on display. The Getein 1160, a flagship FIA device, continues to generate strong interest, while the Getein 1150 — with its POS-terminal-sized portability and rapid testing capability — has sparked particular curiosity among visitors seeking solutions for emergency response and space-constrained environments. Also featured are the GN 7000 Akso PCR System, with a fully enclosed system and microfluidic design for "sample in, result out" molecular testing, delivering results within 30 minutes; the CA-5500 automated coagulation analyzer; and the CM-50 Vet veterinary clinical chemistry analyzer — together underscoring Ge...